The estimated Net Worth of Zhengguang Lyu is at least 119 千$ dollars as of 30 November 2016. Zhengguang Lyu owns over 34,337 units of MYOS RENS Technology stock worth over 119,020$ and over the last 8 years Zhengguang sold MYOS stock worth over 0$.
Sign up
Zhengguang Lyu MYOS stock SEC Form 4 insiders trading
Zhengguang has made over 4 trades of the MYOS RENS Technology stock since 2016, according to the Form 4 filled with the SEC. Most recently Zhengguang bought 34,337 units of MYOS stock worth 49,789$ on 30 November 2016.
The largest trade Zhengguang's ever made was buying 50,000 units of MYOS RENS Technology stock on 23 September 2016 worth over 85,000$. On average, Zhengguang trades about 23,568 units every 33 days since 2016. As of 30 November 2016 Zhengguang still owns at least 117,842 units of MYOS RENS Technology stock.
You can see the complete history of Zhengguang Lyu stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Zhengguang Lyu's mailing address?
Zhengguang's mailing address filed with the SEC is 16TH FLOOR, BUILDING A, FENGHUO PLAZA, NO.88 YUN LONG SHAN ROAD, NANJING, F4, 210019.
Insiders trading at MYOS RENS Technology
Over the last 12 years, insiders at MYOS RENS Technology have traded over 0$ worth of MYOS RENS Technology stock and bought 2,115,845 units worth 2,654,259$ . The most active insiders traders include David J Matlin、Christopher Pechock、Joseph Mannello. On average, MYOS RENS Technology executives and independent directors trade stock every 78 days with the average trade being worth of 59,361$. The most recent stock trade was executed by Joseph Mannello on 31 March 2020, trading 16,529 units of MYOS stock currently worth 16,694$.
What does MYOS RENS Technology do?
MYOS RENS Technology, Inc. operates as a nutrition company, develops and markets products that improve muscle health and performance. Its primary product is Fortetropin, a proprietary bioactive composition derived from fertilized egg yolk, intended to increase lean muscle mass, size, and strength. The company was founded on April 11, 2007 and is headquartered in Cedar Knolls, NJ.
What does MYOS RENS Technology's logo look like?
Complete history of Zhengguang Lyu stock trades at MYOS RENS Technology
MYOS RENS Technology executives and stock owners
MYOS RENS Technology executives and other stock owners filed with the SEC include:
-
Joseph Mannello,
Chief Executive Officer, Director -
Robert Hariri,
Independent Chairman of the Board -
Eric Zaltas,
Independent Director -
Andrew Ponte,
Independent Director -
Christopher Pechock,
Independent Director -
Victor Mandel,
Independent Director -
Christopher Dewey,
Independent Director -
Louis Aronne,
Independent Director -
Ren Ren,
Director -
Sapna Srivastava,
Director -
Joseph Dos Santos,
Chief Financial Officer -
Kenrick Bryce Toussaint,
Chief Executive Officer -
Buzz Aldrin,
Director -
Zhengguang Lyu,
Director -
Robert C. Jr. Ashton,
Chief Medical Officer -
Peter Diamandis,
Director -
John Craig Venter,
Director -
Peter Levy,
COO & Executive VP -
John Nosta,
Director -
Carl De Freitas,
Interim CFO -
Glen R. Fleischer,
Chief Executive Officer -
David J Matlin,
10% owner